Literature DB >> 10962344

Femoral morphology and cross-sectional geometry of adult myostatin-deficient mice.

M W Hamrick1, A C McPherron, C O Lovejoy, J Hudson.   

Abstract

GDF-8, also known as myostatin, is a member of the transforming growth factor-beta (TGF-beta) superfamily of secreted growth and differentiation factors that is expressed in vertebrate skeletal muscle. Myostatin functions as a negative regulator of skeletal muscle growth and myostatin null mice show a doubling of muscle mass compared with normal mice. We examined femoral morphology of adult myostatin-deficient mice to assess the effects of muscle fiber hypertrophy and hyperplasia on bone shape and cross-sectional geometry. Femora of age- and weight-matched adult mice homozygous for the disrupted myostatin sequence were compared with those of wild-type controls (n = 8 per group). Results show that, as was the case in previous studies, myostatin null mice have hindlimb muscle masses that are approximately double those of controls. Myostatin-deficient mice exhibit third trochanters that are significantly larger than those of controls, whereas the femoral midshafts of the control and experimental mice do not differ significantly from one another in cortical area, bending moment of inertia, and polar moment of inertia. Our findings indicate that the increased muscle mass of myostatin-deficient mice primarily affects sites of muscle insertion, but does not induce additional cortical bone deposition in the diaphysis relative to controls. We therefore conclude that the expanded third trochanters of myostatin-deficient subjects result from tendon and Sharpey fiber expansion associated with muscle growth rather than cortical bone deposition in response to increased levels of mechanical stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962344     DOI: 10.1016/s8756-3282(00)00339-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  27 in total

1.  The relationship between bone mechanical properties and ground reaction forces in normal and hypermuscular mice.

Authors:  Daniel Schmitt; Ann C Zumwalt; Mark W Hamrick
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2010-07-01

2.  Bone mineral mass in males and females with and without Down syndrome.

Authors:  Fatima Baptista; Ana Varela; Luis B Sardinha
Journal:  Osteoporos Int       Date:  2004-09-09       Impact factor: 4.507

3.  Exercise mitigates the stunting effect of cold temperature on limb elongation in mice by increasing solute delivery to the growth plate.

Authors:  Maria A Serrat; Rebecca M Williams; Cornelia E Farnum
Journal:  J Appl Physiol (1985)       Date:  2010-10-07

4.  Contribution of myostatin gene polymorphisms to normal variation in lean mass, fat mass and peak BMD in Chinese male offspring.

Authors:  Hua Yue; Jin-wei He; Hao Zhang; Chun Wang; Wei-wei Hu; Jie-mei Gu; Yao-hua Ke; Wen-zhen Fu; Yun-qiu Hu; Miao Li; Yu-juan Liu; Song-hua Wu; Zhen-lin Zhang
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

5.  Myostatin regulates tissue potency and cardiac calcium-handling proteins.

Authors:  Melissa F Jackson; Naisi Li; Buel D Rodgers
Journal:  Endocrinology       Date:  2014-02-11       Impact factor: 4.736

6.  Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice.

Authors:  Alison M Muir; Yinshi Ren; Delana Hopkins Butz; Nicholas A Davis; Robert D Blank; David E Birk; Se-Jin Lee; David Rowe; Jian Q Feng; Daniel S Greenspan
Journal:  Hum Mol Genet       Date:  2014-01-12       Impact factor: 6.150

7.  Administration of an activin receptor IIB ligand trap protects male juvenile rhesus macaques from simian immunodeficiency virus-associated bone loss.

Authors:  Wen Guo; Karol M Pencina; Karyn O'Connell; Monty Montano; Liming Peng; Susan Westmoreland; Julie Glowacki; Shalender Bhasin
Journal:  Bone       Date:  2017-01-26       Impact factor: 4.398

Review 8.  A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation.

Authors:  Michael A Rosenberg; Saumya Das; Pablo Quintero Pinzon; Ashley C Knight; David E Sosnovik; Patrick T Ellinor; Anthony Rosenzweig
Journal:  J Atr Fibrillation       Date:  2012-02-02

9.  Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.

Authors:  Brian C Goh; Vandana Singhal; Angelica J Herrera; Ryan E Tomlinson; Soohyun Kim; Marie-Claude Faugere; Emily L Germain-Lee; Thomas L Clemens; Se-Jin Lee; Douglas J DiGirolamo
Journal:  J Biol Chem       Date:  2017-06-28       Impact factor: 5.157

10.  Single nucleotide polymorphisms in the upstream regulatory region alter the expression of myostatin.

Authors:  Wei Hu; Songyu Chen; Ran Zhang; Yushuang Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-14       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.